{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:46:21Z","timestamp":1782733581773,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pedneo.2025.10.009","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:16:17Z","timestamp":1767208577000},"page":"431-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for neonatal abstinence syndrome in infants born to mothers using psychotropic medications: A cohort study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-1635","authenticated-orcid":false,"given":"Koji","family":"Nakae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-6441","authenticated-orcid":false,"given":"Yasuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2025.10.009_bib1","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2025.10.009_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOP.0b013e32834fdc3a","article-title":"Neonatal abstinence syndrome","volume":"24","author":"Jansson","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.pedneo.2025.10.009_bib3","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2025.10.009_bib4","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"10.1016\/j.pedneo.2025.10.009_bib5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2025.10.009_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.pedneo.2025.10.009_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/S1092852920001522","article-title":"Head circumference in infants with nonopiate-induced neonatal abstinence syndrome","volume":"26","author":"Morimoto","year":"2021","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pedneo.2025.10.009_bib8","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.pedneo.2025.10.009_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/NDT.S36394","article-title":"The use of psychotropic medication during pregnancy: how about the newborn?","volume":"9","author":"Kieviet","year":"2013","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.pedneo.2025.10.009_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jad.2021.12.117","article-title":"Causal model of the association of social support during pregnancy with a perinatal and postpartum depressive state: a nationwide birth cohort - the Japan Environment and Children's Study","volume":"300","author":"Matsumura","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pedneo.2025.10.009_bib11","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.2174\/092986712803306349","article-title":"Selective serotonin reuptake inhibitors in pregnancy","volume":"19","author":"Bellissima","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pedneo.2025.10.009_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2042098614522682","article-title":"Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects","volume":"5","author":"Galbally","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.pedneo.2025.10.009_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/brainsci9090235","article-title":"Use of prescribed psychotropics during pregnancy: a systematic review of pregnancy, neonatal, and childhood outcomes","volume":"9","author":"Creeley","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.pedneo.2025.10.009_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/neurolint13040062","article-title":"Anesthetic considerations for patients on psychotropic drug therapies","volume":"13","author":"Harbell","year":"2021","journal-title":"Neurol Int"},{"key":"10.1016\/j.pedneo.2025.10.009_bib15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-007393","article-title":"Evaluating definitions for neonatal abstinence syndrome","volume":"147","author":"Doherty","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2025.10.009_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.pedneo.2025.10.009_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1192\/bjp.bp.112.115931","article-title":"Maternal depression, antidepressant use in pregnancy and Apgar scores in infants","volume":"202","author":"Jensen","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pedneo.2025.10.009_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1394682","article-title":"Neonatal abstinence syndrome and infant mortality and morbidity: a population-based study","volume":"12","author":"Lisonkova","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pedneo.2025.10.009_bib19","first-page":"13","article-title":"Effects of maternal psychotropic drug dosage on birth outcomes","volume":"10","author":"Michielsen","year":"2014","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1016\/j.pedneo.2025.10.009_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2025.10.009_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fped.2019.00309","article-title":"Neonatal outcomes in maternal depression in relation to intrauterine drug exposure","volume":"7","author":"Corti","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pedneo.2025.10.009_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41372-020-0644-y","article-title":"Maternal antidepressant use during pregnancy and neonatal hypoglycemia: prospective cohort study","volume":"40","author":"Shah","year":"2020","journal-title":"J Perinatol"},{"key":"10.1016\/j.pedneo.2025.10.009_bib23","first-page":"311","article-title":"Antipsychotic exposure in pregnancy and the risk of gestational diabetes: a systematic review and meta-analysis","volume":"46","author":"Kucukgoncu","year":"2020","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pedneo.2025.10.009_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.pedneo.2025.10.009_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061328","article-title":"Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study","volume":"12","author":"Heinonen","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.pedneo.2025.10.009_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1192\/pb.bp.114.048793","article-title":"Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression","volume":"39","author":"Loebel","year":"2015","journal-title":"BJPsych Bull"},{"key":"10.1016\/j.pedneo.2025.10.009_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41390-021-01756-4","article-title":"Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors","volume":"91","author":"Bakhireva","year":"2022","journal-title":"Pediatr Res"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957225002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957225002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:16:46Z","timestamp":1782731806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957225002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1875957225002438"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2025.10.009","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for neonatal abstinence syndrome in infants born to mothers using psychotropic medications: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2025.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}